This inventor holds 2 USPTO granted patents. Top assignee: Daewoong Pharmaceutical Co., Ltd.. Active years: 2016-2017.
Company Filing History:
Years Active: 2016-2017
Title: Taek-Joo Lim: Innovator in Pharmaceutical Composition
Introduction
Taek-Joo Lim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hyperlipidemia and hypertriglyceridemia. With a total of 2 patents, his work is recognized for its innovative approach to addressing these health issues.
Latest Patents
Lim's latest patents include a pharmaceutical composition for preventing or treating hyperlipidemia. This composition comprises (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or its pharmaceutically acceptable salt, along with an angiotensin II receptor blocker as active ingredients. Another notable patent is a method for treating hypertriglyceridemia, which includes the same oxazolidinone compound and amlodipine or its pharmaceutically acceptable salt at a synergistic ratio of about 4:1.
Career Highlights
Taek-Joo Lim is currently associated with Daewoong Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing effective treatments for lipid-related health conditions.
Collaborations
Lim has collaborated with notable colleagues, including Jong-Wook Lee and Sang-Ho Lee, contributing to the advancement of pharmaceutical research and development.
Conclusion
Taek-Joo Lim's contributions to pharmaceutical innovations highlight his commitment to improving health outcomes through effective treatments. His patents reflect a deep understanding of complex medical conditions and a dedication to advancing medical science.